FDA tells Purell to stop claiming it can prevent flu

Marketing campaign also claims product can prevent ebola spread


The Food and Drug Administration (FDA) told the maker of Purell to discontinue marketing campaigns that includes claims for avoiding flu and ebola, according to an article on The New York Times website.

The campaigns also claim the product can prevent spread of MRSA and norovirus.

The FDA told Gojo Industries that its claims that Purell could reduce the potential for infection or prevent illnesses violated the Federal Food, Drug and Cosmetic Act. 

The agency said it was reclassifying Purell as an unapproved drug, rather than an over-the-counter product.

Read the article.



February 10, 2020


Topic Area: Infection Control

Recent Posts

Designing a Home Away from Home

Ronald McDonald House Atlanta balances the familiarity of home with the demands of a high-use facility serving families of children receiving medical care.

Stephens County Hospital Becoming Part of Wellstar Health System

The transaction is expected to be completed toward the end of 2026, pending the conclusion of regulatory approvals.

Grafton City Hospital Joins Vandalia Health

The transition follows approval from the West Virginia Health Care Authority and continues a longstanding partnership between the organizations.

Protecting Patients from C. auris Through Bed and Mattress Safety

Managers face an urgent question: What happens when a colonized patient returns to a contaminated mattress?

Geisinger Wyoming Valley Medical Center Tops Off New Acute Care Tower

The new acute care tower, designed by FCA, will enhance the hospital’s ability to serve patients by incorporating facilities and expanding its range of services.

 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.